Osteoporosis: In postmenopausal women with low levels of estrogen By Jeffrey Brimmer Bio475 Seminar - PowerPoint PPT Presentation

1 / 9
About This Presentation
Title:

Osteoporosis: In postmenopausal women with low levels of estrogen By Jeffrey Brimmer Bio475 Seminar

Description:

Bone is the living tissue that supports our muscles, protects our ... Biller, B.M., V. Saxe, D.B. Herzog, D.I Rosenthal, S. Holzman, and A. Klibanski. 1989. ... – PowerPoint PPT presentation

Number of Views:73
Avg rating:3.0/5.0
Slides: 10
Provided by: LAWNMO
Category:

less

Transcript and Presenter's Notes

Title: Osteoporosis: In postmenopausal women with low levels of estrogen By Jeffrey Brimmer Bio475 Seminar


1
Osteoporosis In postmenopausal women with low
levels of estrogen By Jeffrey Brimmer
Bio-475 SeminarDr. Lin

2
What is bone?
  • Bone is the living tissue that supports our
    muscles, protects our organs, and stores most of
    the calcium in the body.

The McMillan Visual Dictionary, McMillan
Publishing Company, 1992
3
What are osteoblasts and osteoclasts?
  • An osteoblast is a mononucleate cell that is
    responsible for the formation of bone.
  • An osteoclast is a bone cell that removes bones
    mineralized matrix in a process called bone
    resorption.

Kölliker
4
What is osteoporosis?
  • It a disease of the bones in which bone mineral
    density is reduced and the micro architecture is
    altered.
  • There is an imbalance between bone resorption and
    bone formation.

National Institute of Arthritis and
Musculoskeletal and Skin Diseases
5
Causes of osteoporosis
  • Osteoporosis is caused by the break down of bone
    density because osteoblasts are not forming bone
    fast enough or bone resorption is not taking
    place.
  • There is a lack of glucocorticoid hormone to
    increase osteoclast activity.
  • A lack of exercise could also lead to
    osteoporosis.
  • In women, a lack of estrogen increases bone
    resorption and decreases the deposit of bone.
  • The lack of vitamin D and calcium in a persons
    diet can lead to impaired bone deposition.
  • With a lack of calcium in the blood more
    parathyroid hormone is released which increases
    bone resorption.

6
Menopause
  • The permanent physiological stop of the menstrual
    cycle in women.
  • Triggered by the deterioration or shut down of
    the ovaries production of estrogen.
  • One of estrogens main functions is to reduce bone
    resorption and increases the formation of new
    bone.

7
Epidemiology of osteoporosis
  • Affects both men and women, but is especially
    seen in women.
  • Estimated that one in three women have
    osteoporosis.
  • Most prevalent in non-Hispanic white, and Asian
    women.
  • Hip fractures, vertebral factures, and distal
    radius fractures are among the most common
    fractures seen in people with osteoporosis.

8
Possible treatments of osteoporosis
  • Hormone replacement therapy in women to increase
    estrogen levels.
  • Bisphosphonates are drugs that inhibit osteoblast
    action and resorption of bone.
  • Teriparatide is a recombinant form of parathyroid
    hormone.
  • Strontium ranelate is drug taken orally.

9
References
  • Biller, B.M., V. Saxe, D.B. Herzog, D.I
    Rosenthal, S. Holzman, and A. Klibanski. 1989.
    Mechanisms of osteoporosis in adult and
    adolescent women with anorexia nervosa. The
    Journal of clinical endocrinology and metabolism.
    68 548-554. Retrieved 19 Sept 2007.
  • http//jcem.endojournals.org/cgi/content/abstract/
    68/3/548
  • Falhammar, H, H. Filipsson, G. Holmdahl, P.O.
    Janson, A. Nordenskjöld, K. Hagenfeldt, and M.
    Thorén. 2007. Fractures and bone mineral density
    in adult women with 21-hydroxylase deficiency.
    The Journal of clinical endocrinology and
    metabolism. 10 1210. Retrieved 19 Sept 2007.
    http//jcem.endojournals.org/cgi/rapidpdf/jc.2007-
    0744v1
  • Guardia, G., N. Parikh, T. Eskridge, E.
    Phillips, G. Divine, and D.S. Rao. 2007.
    Prevalence of vitamin D depletion among subjects
    seeking advice on osteoporosis a five-year
    cross-sectional study with public health
    implications. Osteoporosis international. 10
    1007. Retrieved 19 Sept 2007. http//www.ncbi.nlm.
    nih.gov/sites/entrez?DbpubmedCmdShowDetailView
    TermToSearch17876644ordinalpos1itoolEntrezSys
    tem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVD
    ocSum
  • Lewiecki, E.M. 2007. Long dosing intervals in the
    treatment of postmenopausal osteoporosis. Current
    medical research and opinion. Retrieved 19 Sept
    2007. http//www.ncbi.nlm.nih.gov/sites/entrez?Db
    pubmedCmdShowDetailViewTermToSearch17868504or
    dinalpos1itoolEntrezSystem2.PEntrez.Pubmed.Pubm
    ed_ResultsPanel.Pubmed_RVDocSum
Write a Comment
User Comments (0)
About PowerShow.com